Clinical Characteristics and Long-term Visual Prognosis of Familial Exudative Vitreoretinopathy

To investigate the clinical characteristics and long-term visual outcomes of familial exudative vitreoretinopathy (FEVR).

Retrospective case series.

Patients diagnosed with FEVR and treated at Ramathibodi Hospital, Bangkok, Thailand, between January 2007 and February 2024.

Medical records were reviewed for demographic data, clinical features, management, and visual outcomes. Logistic regression was used to identify predictors of visual outcomes.

Clinical characteristics, treatment modalities, surgical success, and visual outcomes.

Ninety-two eyes of 46 patients were included. The median (interquartile range) age of onset was 6.4 (2.0-24.0) months. FEVR stages 1, 2, 3, 4, and 5 were observed in 38.0%, 13.0%, 6.6%, 26.1%, and 16.3% of eyes, respectively. Retinal vessel abnormalities (55.4%) were the most common posterior finding. Overall, 62.0% of eyes required no treatment, 34.8% underwent laser photocoagulation, and 7.6% received surgery (pneumatic retinopexy [PR], pars plana vitrectomy with silicone oil [PPV+SO], or scleral buckling). The surgical success rate was 42.9%. Peripheral avascular retina <9 clock-hours was significantly associated with better visual outcomes, with an OR (95% CI) of 3.61 (1.06, 12.32). Disc dragging, macular dragging, and retinal detachment were associated with worse outcomes, with ORs (95% CI) of 0.12 (0.04-0.36), 0.04 (0.01-0.15), and 0.03 (0.01-0.12), respectively. Stage 4 disease independently predicted poor outcome with adjusted OR (95% CI) of 0.05 (0.00-0.82), P = .036).

Most patients with FEVR presented with mild disease requiring no treatment, Despite successful treatment, advanced stages (≥4) were significantly associated with poor vision. When appropriately selected, PPV+SO and PR have potential benefits, particularly in achieving anatomical attachment.